PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...

Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...

GOLDEN, Colo., November 04, 2025--(BUSINESS WIRE)--PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its needle-free injection technology, will present at ...

There were significantly fewer adverse events associated with needle-free Tropis ® intradermal (ID) delivery as compared to needle and syringe (N/S). Tropis ID delivery was preferred over N/S ID ...

PharmaJet, a commercial-stage world leader in needle-free injection systems to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that it ...

The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...